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Two cases of aberrant migration by the liver fluke Fasciola gigantica in humans are reported. In both cases,
subadult worms emerged through the skin. The identity of the worms was confirmed from their DNA sequences.
This uncommon human pathogen might be more likely than F. hepatica to undertake aberrant migrations in
humans.
CASE REPORTS
Case 1. In May 2002, an 11-year-old girl from a province
near Hanoi, Vietnam, complained of fever and pain in her
abdominal region. On admission to Bach Mai National Hos-
pital, her temperature was 39°C and she was diagnosed as
having a liver abscess. She was transferred to Hanoi National
Children’s Hospital. The fever persisted throughout June and
July 2002. Over this 3-month period, her weight dropped from
30 kg to 18 kg. Computed tomography (CT) scans showed two
abscesses, each 2.5 cm by 4 cm, in her liver. Her eosinophilia
was about 29%. Her lungs and heart were normal by X-ray
photography. The patient underwent abdominal surgery for
inspection of the liver for an abscess or a tumor. No lesions
were observed on her liver. She was treated with antibiotics
and traditional herbs. With no fever and showing good recov-
ery, the patient was discharged at the end of July 2002.
In August 2002, she felt pain on her knee associated with a
reddish, itchy, and inflamed swelling. While being treated in
Hanoi Public Hospital E, a puncture on her knee was seen, and
through this hole a vigorously moving, pink-colored flat fluke
of 1.5 cm by 2.5 cm emerged. On the basis of its shape, the
fluke was regarded as Fasciola gigantica, and a portion was kept
in 70% ethanol for molecular identification. The spontaneous
emergence of the fluke from the knee was 4 months after the
appearance of the first diagnostic signals in the liver and 1
month after the appearance of the lesion on the knee. Serum
collected when the fluke emerged yielded a titer of 1:12,800 by
a standard enzyme-linked immunosorbent assay protocol (20)
with native excreted-secreted protein antigen produced from
Fasciola gigantica (by use of a slight modification of a previ-
ously described method [4, 11]). After the emergence of the
worm, all clinical symptoms, on the knee and elsewhere, dis-
appeared and the patient remains completely healthy.
Case 2. A 48-year-old Vietnamese woman from Quang Binh
Province in central Vietnam presented to a local district hos-
pital in February 2005 with periumbilical abdominal pain, high
fever, and severe dizziness which was most pronounced in the
late afternoon. The patient was examined by local doctors and
diagnosed as having fascioliasis, and she was admitted to the
Hue City Hospital. Taken together, the results of ultrasound
scanning and serology (as described for case 1) confirmed the
diagnosis of fascioliasis. She was given praziquantel (Disto-
cide), a drug routinely prescribed for the treatment of trema-
tode infections in Vietnam, to be taken in three courses at
monthly intervals (note that triclabenzadole is now the drug of
choice in Vietnam when fascioliasis is diagnosed). For the first
two courses, she took two tablets (600 mg/tablet) per day for 2
days. In the third month, she took two tablets (600 mg/tablet)
per day for 3 days. The patient’s health improved, but her
recovery was not regarded as complete. At the end of April
2005, a small red hard mass appeared on the skin of the left
chest. The mass was painful and itchy, and the patient some-
times felt something moving in the mass. One month later the
mass faded but another distinct red spot appeared on the skin
of the right chest, and for a short time there was a tunnel
linking this spot to the previous one. This spot was less painful
but much harder. The patient then presented at the Hanoi
Viet-Duc Hospital. Oncological examination indicated that the
spot was nonmalignant. During the time of admission to the
hospital throughout June and July 2005, ultrasound of the liver
detected no signs of abscess. The patient was treated with
cefuroxime (Zinnat; two tablets [500 mg/tablet] per day for 10
days). In October 2005, 8 months after the first signs of fasci-
oliasis and 5 months after the first appearance of the tumor in
the right chest, a very hot, red, itchy swelling appeared in the
right breast not far from the previous spot in the right chest.
The fever and dizziness returned. The patient was admitted to
the Quang Binh provincial hospital, diagnosed as having ab-
scess of the right breast and given prazepam (Centrax) (three
vials [1 g/vial] per day for 15 days) for anxiety. The spot was
punctured weekly for collection of exudate. On the second
occasion on which this was done, in early December 2005, a
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fluke about 1 cm wide and 2 cm long crawled out of the
puncture site. It appeared to be a Fasciola species. This fluke
was kept in 70% ethanol prior to molecular identification.
After the emergence of the fluke, the patient felt no unusual
symptoms, was kept under observation for 4 days in the hos-
pital, and then returned home. One month later, in mid-Jan-
uary 2006, the patient was examined again and appeared to be
in good health. The sites of the spots had faded to a dark color,
and the hole where the fluke had emerged was visible only as
a red point.
DNA sequences from the second internal transcribed spacer
(ITS2; 361 bp were used in the analyses) of the nuclear ribo-
somal region and from portions of the mitochondrial nad1 (456
bp) and cox1 (402 bp) genes were obtained from the worm
specimens from the two cases reported here by previously
reported methods (1). The primers used for the PCR are
shown in Table 1. The same gene regions were sequenced by us
from a number of Fasciola samples collected in Vietnam and
other countries (Australia, China, Indonesia, Uruguay).
BLAST searches of the GenBank sequence database and com-
parisons with our own data clearly demonstrated that the
flukes from the Vietnamese patients were pure Fasciola gigan-
tica. It should be noted that hybrids between the two Fasciola
species are known to exist in eastern Asia (1) and that their
presence has recently been demonstrated in Vietnam by the
use of molecular data (T. H. Le et al., data not shown). Hybrids
inherit ITS2 sequences from both parents but inherit mito-
chondrial sequences only from the maternal species. ITS2 se-
quences of the two Fasciola species typically differ at five to six
sites and by one single-base insertion/deletion. The intraspe-
cific variation in the ITS2 region among isolates from eastern
Asia is usually no greater than one site for either species (8, 9),
although greater differences have been noted when specimens
from other continents, especially Africa, have been considered
(16). A typical ITS2 sequence for F. gigantica is GenBank
accession number AB207149, and that for F. hepatica is GenBank
accession number AB207148.
The mitochondrial sequences of the two species differ at
many more sites than is the case for ITS2. However, there is
also more intraspecific variation. For example, in the 392-bp
region in which our nad1 sequences overlap with most of those
available in GenBank, the two species differ at 27 to 37 sites.
Intraspecific variation in Asian F. gigantica strains occurs at up
to 7 sites (and at up to 24 sites if the sequences of strains from
southern Africa are included) and in F. hepatica strains at
4 sites. A typical nad1 sequence for Asian F. gigantica is
GenBank accession number AB207158, and that for F. hepat-
ica is GenBank accession number AB207156. Taken together,
ITS2 and mitochondrial sequences permit identification of
both Fasciola species and their hybrids.
The two unrelated cases reported here resembled a case
previously described from Vietnam, also in a woman (21). In
all three cases, the worm had made an aberrant migration
culminating in emergence through the skin at sites far from the
liver or intestine. The presence of a liver abscess was suspected
or confirmed. In none of the cases had the worms matured.
Fasciola species in ectopic sites generally do not mature (13).
Fasciola species are primarily parasites of ruminants but may
infect humans and can cause considerable pathology. Metacer-
cariae form cysts on edible aquatic vegetation. Excysted meta-
cercariae penetrate the intestinal wall and normally migrate to
the liver, where they mature in the bile ducts and release eggs.
In the liver they can form abscesses, often leading to a misdi-
agnosis of liver cancer by ultrasound or CT scanning, unless
fascioliasis is suspected and appropriate serological tests are
done. Some juveniles fail to localize in the liver and wander
through the body (15). Fasciola hepatica, the better-known
species, occurs in cooler climates than its more tropical con-
gener, F. gigantica. However, the two species overlap in distri-
bution in some places where human fascioliasis is common
(best documented from Egypt [6, 10] and Iran [2]), and hybrids
exist in eastern Asia and perhaps elsewhere (1). Distinguishing
between adult F. hepatica and F. gigantica on the basis of
morphology is possible, but much variation exists (10, 12). In
places where hybrid populations occur, a range of morpholo-
gies that confound identification is seen. Differentiating be-
tween the two species in human infections is not possible on
the basis of clinical, pathological, or immunological findings;
and their eggs are very similar (12, 14). Consequently, in many
places where both species occur, it is not possible to be certain
whether both are responsible for human fascioliasis. In regions
where only F. gigantica occurs, human infection with this par-
asite is known (e.g., in Hawaii [17] and Africa [7]). However,
the extent to which human infection with F. gigantica actually
occurs relative to the extent of exposure to infective stages
(encysted metacercariae on edible aquatic vegetation) remains
rather unclear. To quote Marcilla et al. (12) “the low number
of records of human infection with F. gigantica may well be due
to the lack of good tools to distinguish this species from F.
hepatica”.
There are hints in the literature that humans might be poor
hosts for F. gigantica (17) and that this parasite undertakes
ectopic migrations more often than its congener (19). How-
ever, F. gigantica can mature normally in humans, as demon-
strated by the discovery of adult specimens during surgery or
on postmortem examination (18, 19). Both species are as-
sumed to infect humans in Egypt (6), and F. gigantica is
thought to be the more common species infecting humans in
northern Iran (2). In neither place is ectopic infection appar-
ently frequent. A review of fascioliasis cases in Vietnam (20)
noted that there had been a huge increase in the number of
reported cases of human fascioliasis in that country in the past
TABLE 1. Primer pairs used for amplification of the entire nuclear
ITS2 region and portions of the mitochondrial nad1 and cox1 genesa
Primers Targetgene Sequence (533)
Size of
amplicon
(bp)
FND1F nad1 TGGGGTCTGTTGCAGAGATTTGC 465b
FND1R nad1 ATCCAATGGAGTACGGTTACA
JB3F cox1 TTTTTTGGGCATCCTGAGGTTTAT 448b
JB4.5R cox1 TAAAGAAAGAACATAATGAAAATG
3SF ITS2 GGTACCGGTGGATCACTCGGCTCGTG 556c
BD2R ITS2 TATGCTTAAATTCAGCGGGT
a The same primers were used for sequencing of the cloned amplicons.
b The regions used for analysis were slightly shorter than this (see text).
c Includes flanking regions and portions of the 5.8S and 28S genes that were
not used in analysis.
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decade. Of 500 cases diagnosed by serology and clinical signs
and summarized elsewhere (1), only 2 had worms in atypical
sites. Almost all Vietnamese cases have been ascribed to F.
gigantica (5).
It is clear that more data about the relative prevalences of F.
gigantica and F. hepatica in humans are needed in order to
evaluate clinical findings. It is easy to distinguish between the
species by molecular analyses, such as DNA sequencing (also
reviewed elsewhere [14]). In this paper, we have presented the
first molecular confirmation of the presence of F. gigantica in
humans. In the future, amplification and sequencing of DNA
extracted from Fasciola eggs from patients with patent infec-
tions should throw light on the contributions made by the two
Fasciola species to human fascioliasis. An example has been set
by the sequencing of DNA from eggs, recovered from human
sputum, of Paragonimus westermani (3). Rapid real-time PCR
assays can also be devised. Of course, the identities of imma-
ture worms in ectopic cases will remain unclear unless they
emerge spontaneously or can be recovered by medical inter-
vention.
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